Cipla Limited reported Total Income for Q4 FY23 of ₹5,873.93 Crore up from ₹5,324.35 Crore year on year, a growth of 10.3%. Consolidated Net Profit of ₹521.51 Crore, up 40.7% from ₹370.70 Crore in the same quarter of the previous year. The Earnings per Share is ₹6.51, from ₹4.48 in the same quarter of the previous year.
Cipla Limited Q4 FY23; Consolidated Net Profit Jumped By 41%
Tags: pharmaceuticals
Related Post
- Edelweiss Financial Services Limited charts multi-year growth across asset management and insurance businesses
Edelweiss Financial Services Limited (NSE: EDELWEISS, BSE: 532922) presented a multi-year snapshot of growth across…
-
Aarti Pharmalabs Limited reports sequential margin recovery in Q3 FY26 as CDMO transit impact weighs on revenue
Aarti Pharmalabs Limited (NSE: AARTIPHARM, BSE: 543748) reported a sequential improvement in operating performance in…
-
Earnings Summary: G R Infraprojects Limited reports higher Q3 FY26 income as execution accelerates; margins stable
G R Infraprojects Limited (NSE: GRINFRA, BSE: 543317) reported higher income for the quarter ended…